CD147 inhibitors as a treatment for melanoma: Promising agents against SARS-CoV-2 infection.

Pourani, Mohammad Reza; Nekooghadam, Sayyed Mojtaba; Youssefian, Leila; Vahidnezhad, Hassan; Abdollahimajd, Fahimeh

Pourani, Mohammad Reza; Nekooghadam, Sayyed Mojtaba; Youssefian, Leila; Vahidnezhad, Hassan; Abdollahimajd, Fahimeh.

Pourani MR; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nekooghadam SM; Internal Department of Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Youssefian L; Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Vahidnezhad H; Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Abdollahimajd F; Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Dermatol Ther ; 33(6): e14449, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-1388246

Subject(s)

Antineoplastic Agents/therapeutic use; Antiviral Agents/therapeutic use; Basigin/antagonists & inhibitors; COVID-19 Drug Treatment; Melanoma/drug therapy; SARS-CoV-2/drug effects; Skin Neoplasms/drug therapy; Animals; Basigin/metabolism; COVID-19/immunology; COVID-19/metabolism; COVID-19/virology; Host-Pathogen Interactions; Humans; Melanoma/immunology; SARS-CoV-2/immunology; SARS-CoV-2/pathogenicity; Signal Transduction; Skin Neoplasms/immunology; Skin Neoplasms/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Skin Neoplasms / Basigin / SARS-CoV-2 / COVID-19 Drug Treatment / Melanoma / Antineoplastic Agents Limits: Animals / Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: DTH.14449

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google